Sciascia S, et al. 16th International congress on antiphospholipid antibodies task force report on clinical manifestations of antiphospholipid syndrome. Lupus. 2021;30(8):1314–26.
Article CAS PubMed Google Scholar
Barbhaiya M, et al. The 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Arthritis Rheumatol. 2023;75(10):1687–702.
Xourgia E, Tektonidou MG. An update on antiphospholipid syndrome. Curr Rheumatol Rep. 2022;23(12):84.
Duarte-García A, et al. The epidemiology of antiphospholipid syndrome: a population-based study. Arthritis Rheumatol. 2019;71(9):1545–52.
Article PubMed PubMed Central Google Scholar
Dabit JY, et al. Epidemiology of antiphospholipid syndrome in the general population. Curr Rheumatol Rep. 2022;23(12):85.
Article PubMed PubMed Central Google Scholar
Cervera R, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46(4):1019–27.
Zhao Y, et al. Performance validation of the 2023 American College of Rheumatology/European League Against Rheumatism antiphospholipid syndrome classification criteria in an antiphospholipid syndrome cohort. J Thromb Haemost. 2024;22(6):1660–74.
Yang Y, et al. Assessment of the 2023 ACR/EULAR antiphospholipid syndrome classification criteria in a Chinese cohort: Impact on clinical practice. J Autoimmun. 2024;146:103237.
Article CAS PubMed Google Scholar
Cervera R, et al. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis. 2015;74(6):1011–8.
Article CAS PubMed Google Scholar
Liu M, et al. Prevalence, risk factors, and prognosis of central nervous system manifestations in antiphospholipid syndrome. Sci Rep. 2023;13(1):8915.
Article CAS PubMed PubMed Central Google Scholar
Cervera R, et al. The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe. Lupus. 2009;18(10):889–93.
Article CAS PubMed Google Scholar
Sciascia S, et al. The estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic review. Ann Rheum Dis. 2015;74(11):2028–33.
Article CAS PubMed Google Scholar
Asherson RA, Cervera R. Catastrophic antiphospholipid syndrome. Curr Rheumatol Rep. 2003;5(5):395–400.
Asherson RA, Cervera R. The antiphospholipid syndrome: multiple faces beyond the classical presentation. Autoimmun Rev. 2003;2(3):140–51.
Erkan D, Cervera R, Asherson RA. Catastrophic antiphospholipid syndrome: where do we stand? Arthritis Rheum. 2003;48(12):3320–7.
Cervera R, et al. 16th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome. Lupus. 2020;29(12):1594–600.
Cervera R, Rodríguez-Pintó I, Espinosa G. The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: A comprehensive review. J Autoimmun. 2018;92:1–11.
Green D. Pathophysiology of Antiphospholipid Syndrome. Thromb Haemost. 2022;122(7):1085–95.
Article PubMed PubMed Central Google Scholar
Knight JS, Kanthi Y. Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome. Semin Immunopathol. 2022;44(3):347–62.
Article CAS PubMed PubMed Central Google Scholar
Radic M, Pattanaik D. Cellular and Molecular Mechanisms of Anti-Phospholipid Syndrome. Front Immunol. 2018;9:969.
Article PubMed PubMed Central Google Scholar
Raschi E, et al. Antiphospholipid syndrome pathogenesis in 2023: an update of new mechanisms or just a reconsideration of the old ones? Rheumatology (Oxford). 2024;63(Si):Si4-si13.
Tohidi-Esfahani I, et al. Platelets and thrombotic antiphospholipid syndrome. J Clin Med. 2024;13(3):741.
Article CAS PubMed PubMed Central Google Scholar
D’Ippolito S, et al. Antiphospholipid syndrome in pregnancy: new and old pathogenetic mechanisms. Int J Mol Sci. 2023;24(4):3195.
Article CAS PubMed PubMed Central Google Scholar
Al-Ewaidat OA, Naffaa MM. Deciphering mechanisms, prevention strategies, management plans, medications, and research techniques for strokes in systemic lupus erythematosus. Medicines (Basel). 2024;11(7):15.
Gaspar P, Sciascia S, Tektonidou MG. Epidemiology of antiphospholipid syndrome: macro- and microvascular manifestations. Rheumatology (Oxford). 2024;63(Si):Si24-si36.
García-Grimshaw M, et al. Antiphospholipid syndrome-mediated acute cerebrovascular diseases and long-term outcomes. Lupus. 2022;31(2):228–37.
Sevim E, et al. Characteristics of patients with antiphospholipid antibody positivity in the APS ACTION international clinical database and repository. Arthritis Care Res (Hoboken). 2022;74(2):324–35.
Article CAS PubMed Google Scholar
Rodrigues CE, Carvalho JF, Shoenfeld Y. Neurological manifestations of antiphospholipid syndrome. Eur J Clin Invest. 2010;40(4):350–9.
Zolyan A, Crawford JR. Brainstem stroke in a patient with systemic lupus erythematosus and triple antiphospholipid antibody profile. BMJ Case Rep. 2022;15(12):e254147.
Article PubMed PubMed Central Google Scholar
Volkov I, et al. Profiles of criteria and non-criteria anti-phospholipid autoantibodies are associated with clinical phenotypes of the antiphospholipid syndrome. Auto Immun Highlights. 2020;11(1):8.
Article CAS PubMed PubMed Central Google Scholar
Silvis SM, et al. Cerebral venous thrombosis. Nat Rev Neurol. 2017;13(9):555–65.
Jerez-Lienas A, et al. Cerebral vein thrombosis in the antiphospholipid syndrome: analysis of a series of 27 patients and review of the literature. Brain Sci. 2021;11(12):1641.
Article CAS PubMed PubMed Central Google Scholar
Ricarte IF, et al. Neurologic manifestations of antiphospholipid syndrome. Lupus. 2018;27(9):1404–14.
Article CAS PubMed Google Scholar
Fleetwood T, Cantello R, Comi C. Antiphospholipid syndrome and the neurologist: from pathogenesis to therapy. Front Neurol. 2018;9:1001.
Comments (0)